Focus
Computational Biology Investors: Angels and VC Firms
The RaiseHunt database lists 41 Computational Biology investors: 37 angel investors and 4 people at 3 firms. Most list Seed and Series A among their stages; the largest hubs are San Francisco, London and Singapore.
Strongest in San Francisco, London and Singapore
- 41
- Computational Biology investors
- 37
- Angel investors
- 4
- People at VC/PE firms
- 3
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
41 Computational Biology investors
Showing 1-20
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
Emily Melton Founder and Managing Partner at Threshold Ventures | Portola Valley, United States | AngelOperator angel | AIHealthcare | View profile | |
Matthew De Silva Venture Partner at Builders VC | Chicago, United States | AngelOperator angel | AIHealthcare | View profile | |
Elad Gil Co-founder at Color | San Francisco, United States | AngelOperator angel | AIFinTech | View profile | |
Alap Bharadwaj Global Lead and Director, Gemini-for-Good at Google DeepMind | Singapore | Angel | AIHardware | View profile | |
Dheeraj Pandey Co-founder at Param Hansa Values | Los Gatos, United States | AngelOperator angel | AIHealthcare | View profile | |
Demis Hassabis Co-Founder & CEO at Google DeepMind | London, United Kingdom | AngelOperator angel | AIHealthcare | View profile | |
John Leonard Board Member at IQVIA | Cambridge, United States | Angel | AIHealthcare | View profile | |
Simon Crosby CTO at DCVC | Kirkland, United States | AngelOperator angel | AIHardware | View profile | |
Zachary Bogue Cofounder and Managing Partner at DCVC | San Francisco, United States | Angel | AIClimate | View profile | |
Blake Borgeson angel investor and operator angel | Austin, United States | AngelOperator angel | AIHealthcare | View profile | |
Alice Zhang angel investor and operator angel | San Francisco, United States | AngelOperator angel | AIHealthcare | View profile | |
Mark Stoner angel investor and operator angel | San Francisco, United States | AngelOperator angel | AIFinTech | View profile | |
Loong Wang angel investor | Singapore | Angel | AIHardware | View profile | |
Chris Wiggins Associate Professor at Columbia University Technology Management | New York, United States | AngelOperator angel | AIEducation | View profile | |
Chris Leiter Founder & General Partner at Atria Ventures | San Francisco, United States | AngelOperator angel | AIHealthcare | View profile | |
Rob Kniaz Partner Emeritus at Hoxton Ventures | London, United Kingdom | Angel | AIHealthcare | View profile | |
Ori Choshen angel investor and operator angel | Tel Aviv-Yafo, Israel | AngelOperator angel | AIHealthcare | View profile | |
Ian Goodfellow angel investor and operator angel | San Francisco, United States | AngelOperator angel | AIHealthcare | View profile | |
DW David Walt Hansjörg Wyss Professor of Biologically Inspired Engineering at HMS MEDscience | Boston, United States | AngelOperator angel | AIHealthcare | View profile | |
AZ Aaron Zucker Founder & Managing Partner at Sapir Venture Partners | Israel | AngelOperator angel | AIHardware | View profile |
Frequently asked questions
How many Computational Biology investors are on RaiseHunt?
RaiseHunt currently lists 41 Computational Biology investors.
Are Computational Biology investors angels or funds?
Both. 37 are angel investors putting in their own money, and 4 are people making investment decisions at 3 firms.
Where are most Computational Biology investors based?
The largest concentrations are in San Francisco, London and Singapore.
What stage do Computational Biology investors invest at?
Most list Seed and Series A among the rounds they take part in.
How do I contact Computational Biology investors?
Every profile shows whether an email address is on file. The addresses themselves, along with AI matching and outreach, are in the RaiseHunt app.
Is the list of Computational Biology investors free to browse?
Yes. The directory and every profile page are free to read. Matching your own startup against them requires an account.
Do Computational Biology investors only back Computational Biology companies?
No. A focus area is a signal of interest, not a restriction. Investors usually list several, and the useful question is whether their existing portfolio looks like the kind of company you are building.
What should I have ready before reaching out?
A short deck, a one-paragraph description of what you do and who it is for, and a clear number for how much you are raising. Investors read the first two lines before they decide whether to open the deck, so those lines matter more than the rest of the document.
Does a warm introduction still matter?
It helps, mostly because it moves your email out of a crowded inbox. It is not a requirement. A cold message that shows you understand what someone has already backed, and why your company fits that pattern, gets read more often than a vague introduction from a distant contact.
How do I know which Computational Biology investors are a fit?
Look at what they have already funded rather than what their profile says they like. Stage matters most, then sector, then geography. An investor who has never funded anything at your stage is unlikely to start with you, however well the sector lines up.
How long does raising a round usually take?
Longer than most first-time founders plan for. The work splits into building the list, running outreach, taking meetings, and closing, and each stage can stretch. Start before you need the money, not when the runway is short.
What do investors look at first?
The team and the problem, in that order, before the product. Early on there is rarely enough traction to argue from numbers alone, so the question they are answering is whether these particular people are likely to work this problem out.
Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal
